However, members of the miR181 family have been reported as tumor suppressors in other cancers such as AML (70), colorectal cancer (71), and lung cancer (72), and KRAS was recently proposed as a direct target of miR181a in AML (73). This evidence concerns the gene KRAS and lung cancer.